Chartsonlygoup's future update (it'll live): tomwong.xyz/stock-status/

  Intrexon Corp. ( XON ) |
2013 - 2021 (7 years)

Net Revenue (Sales) is 
$69.2M (1Y -46.5% )

XON Stock Price & Net Revenue (Sales)

Net Revenue (Sales) for XON competitors.
ZIOP LLY TMO OMEX
Note: Stonk = Stock. Both words are used interchangeably. 🙂

Historical (All-Time) Stats for Net Revenue (Sales)

chevron_right 2019 $90.7M +2.1x *
( +17.4% / year avg)
chevron_left 2013 -$29.5M
vertical_align_top Peak $231.0M +8.83x *
vertical_align_bottom Bottom -$29.5M
arrow_drop_up # Up Years 4 4 of 7
years up.
arrow_drop_down # Down Years 3
Up Years = Positive (0%+) YoY change
Down Years = Zero or Negative (0% or less) YoY change

Key Points (Stonk Price Comparison)

  • XON's stock price has drop -87.5% from $21.73 in 2013 , or +0.46x the rate relative to it's net revenue (sales) over the same period.
  • If XON grows it's stock at the same rate as it's net revenue (sales) (+17.4%/year) , it's stock price will grow +497% and hit $13.53 over the next 10 years.
  • XON's stock price has gone up 1 of the 4 years (+25%) it's net revenue (sales) were also up.
* A modified method (see: here) is used to calculate changes that involve negative numbers.
  • Line Item (in $M) FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012
    1 Revenue 90722000.00 160600000.00 231000000.00 190900000.00 173600000.00 71900000.00 23800000.00 13800000.00
    2 Cost of Revenue 31930000.00 63300000.00 62800000.00 61600000.00 63900000.00 8200000.00 0.00 0.00
    3 Gross Profit (Income) 58792000.00 97300000.00 168200000.00 129300000.00 109700000.00 63700000.00 23700000.00 13800000.00
    4 R&D 101879000 404600000 143200000 112100000 147500000 105800000 48100000 64000000
    5 SG&A 100844000 137800000 145600000 142300000 109100000 27900000 33600000 24900000
    6 Other Expenses 92211000.00 123791000.00 79561000.00 61639000.00 63929000.00 19260000.00 0.00 0.00
    7 Operating Expenses 294934000.00 602900000.00 306100000.00 254500000.00 256600000.00 133700000.00 81800000.00 88900000.00
    8 Interest Expense 17666000.00 8530000.00 611000.00 861000.00 1244000.00 666000.00 141000.00 0.00
    9 D&A 43193000.00 33110000.00 31150000.00 24570000.00 17740000.00 10420000.00 7210000.00 7980000.00
    10 EBITDA -161019000 -472490000 -106750000 -100630000 -129160000 -59580000 -50790000 -67220000
    11 Operating Income -204212000 -505600000 -137900000 -125200000 -146900000 -70000000 -58000000 -75200000
    12 Other Income Expenses (Net) -2059000.00 600000.00 1000000.00 1700000.00 1300000.00 -200000.00 -200000.00 -100000.00
    13 Pre-Income Tax -208687000 -536200000 -129700000 -173000000 -78000000 -80500000 -40300000 -81600000
    14 Income Tax Expense -930000.00 -21528000.00 -2880000.00 -3877000.00 1016000.00 -103000.00 0.00 0.00
    15 Net Income -322324000 -509300000 -117000000 -186600000 -84500000 -81800000 -39000000 -81900000
    16 EPS -2.09 -3.93 -0.97 -1.58 -0.76 -0.82 -0.95 -14.89
    17 EPS Diluted -2.09 -3.93 -0.97 -1.58 -0.76 -0.82 -0.95 -14.89
    18 Shares Outstanding 154138774.00 129500000.00 120000000.00 118000000.00 111100000.00 99200000.00 41000000.00 5500000.00
    19 Shares Outstanding (Diluted) 154138774.00 129500000.00 120000000.00 118000000.00 111100000.00 99200000.00 41000000.00 5500000.00
  • Line Item (in $M) FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012
    1 Cash & Cash Equivalents 65793000 102800000 68100000 62600000 135800000 27500000 49500000 10400000
    2 Short Term Investments 9260000.00 120100000.00 11600000.00 174600000.00 102500000.00 88500000.00 128000000.00 300000.00
    3 Cash & S-T Investments 75053000 222900000 79700000 237200000 238300000 116000000 177500000 10700000
    4 Accounts Receivables 20650000.00 21200000.00 19800000.00 21600000.00 25100000.00 14600000.00 800000.00 100000.00
    5 Inventory 16097000.00 21400000.00 20500000.00 21100000.00 26600000.00 25800000.00 0.00 0.00
    6 Other Current Assets 122843000.00 7000000.00 7000000.00 7000000.00 0.00 0.00 0.00 0.00
    7 Total Current Assets 234643000 285500000 154000000 315200000 323800000 174800000 187600000 13500000
    8 PP&E 60969000 128900000 112700000 64700000 42700000 38000000 16600000 18700000
    9 Goodwill 63754000.00 149600000.00 153300000.00 157200000.00 165200000.00 101100000.00 13800000.00 0.00
    10 Intangible Assets 68346000 129300000 232900000 225600000 247500000 65900000 42000000 29500000
    11 Goodwill & Intangible Assets 132100000 278900000 386200000 382800000 412700000 167000000 55800000 29500000
    12 L-T Investments 0.00 20800000.00 189900000.00 182700000.00 199100000.00 195200000.00 208400000.00 88800000.00
    13 Tax Assets 15244000.00 7200000.00 15600000.00 17000000.00 21800000.00 0.00 0.00 0.00
    14 Other Non-Current Assets 12807000.00 2100000.00 4100000.00 3700000.00 3700000.00 1300000.00 1100000.00 1100000.00
    15 Total Non-Current Assets 221120000 430694000 692804000 633887000 658200000 401499000 281900000 49300000
    16 Other Assets 0.00 6000.00 96000.00 13000.00 0.00 1000.00 0.00 88800000.00
    17 Total Assets 455763000 716200000 846900000 949100000 982000000 576300000 469500000 151600000
    18 Accounts Payables 5917000.00 13400000.00 8700000.00 8500000.00 5000000.00 6300000.00 1100000.00 600000.00
    19 S-T Debt 31670000.00 500000.00 200000.00 800000.00 600000.00 2300000.00 0.00 0.00
    20 Income Tax Payables 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    21 Deferred Revenue 5697000.00 15554000.00 42870000.00 53364000.00 35366000.00 16522000.00 7793000.00 0.00
    22 Other Current Liabilities 79628000.00 15800000.00 43200000.00 62600000.00 42400000.00 23800000.00 9400000.00 10100000.00
    23 Total Current Liabilities 122912000 61600000 80200000 94600000 75900000 47500000 19800000 16700000
    24 L-T Debt 186321000.00 211200000.00 7500000.00 7600000.00 7600000.00 8700000.00 1700000.00 0.00
  • Line Item (in $M) FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012
    1 Net Income (Earnings) -322324000 -509300000 -117000000 -186600000 -84500000 -81800000 -39000000 -81900000
    2 D&A 43193000.00 33110000.00 31150000.00 24570000.00 17740000.00 10420000.00 7210000.00 7980000.00
    3 Deferred Income Tax 3674000.00 -21280000.00 -2530000.00 -3470000.00 1120000.00 0.00 0.00 0.00
    4 Stock-Based Compensation (SBC) 18950000.00 36296000.00 41576000.00 42202000.00 38667000.00 21849000.00 2921000.00 0.00
    5 Change in Working Capital -112190000.00 -19990000.00 -74160000.00 -10750000.00 58830000.00 12440000.00 -8310000.00 2600000.00
    6 Accounts Receivables -262000.00 -2698000.00 740000.00 2588000.00 -12138000.00 4332000.00 -644000.00 -100000.00
    7 Inventory 4100000.00 -478000.00 663000.00 3807000.00 -774000.00 -7313000.00 0.00 0.00
    8 Accounts Payables -5349000.00 4680000.00 -3402000.00 3618000.00 -3263000.00 1266000.00 -43000.00 2500000.00
    9 Other Working Capital 111731000.00 223921000.00 73874000.00 220576000.00 247897000.00 127291000.00 167727000.00 0.00
    10 Other Non-Cash Items 0.00 398620000.00 68640000.00 130930000.00 45980000.00 42910000.00 -11670000.00 9770000.00
    11 Net Cash Provided by Operating Activities -135927000 -124240000 -103720000 -48990000 35670000 -19860000 -53680000 -61530000
    12 Investments in PP&E -37883000.00 -41587000.00 -46666000.00 -31629000.00 -12749000.00 -6371000.00 -1527000.00 -7490000.00
    13 Acquisitions (Net) 0.00 -920000.00 2054000.00 0.00 -123928000.00 -67577000.00 517000.00 0.00
    14 Purchase of Investments -55073000.00 -178681000.00 -1161000.00 -77554000.00 -198652000.00 -60478000.00 -233979000.00 0.00
    15 Sales/Maturities of Investments 23456000.00 66192000.00 174777000.00 102267000.00 88000000.00 122992000.00 44996000.00 0.00
    16 Other Investing Activities 156351000.00 3783000.00 -24672000.00 -21476000.00 -13482000.00 -14595000.00 -33670000.00 0.00
    17 Net Cash used for Investing Activities 86851000 -151210000 104330000 -28390000 -259250000 -26030000 -223660000 -23640000
    18 Debt Repayment -618000.00 -623000.00 -519000.00 -1201000.00 -1564000.00 -647000.00 -53000.00 0.00
    19 Common Stock Issued 0.00 0.00 0.00 0.00 328234000.00 0.00 0.00 0.00
    20 Common Stock Repurchased -65793000 90330000 14670000 19170000 342700000 26490000 150410000 76030000
    21 Dividends Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    22 Other Financing Activities 74549000.00 413186000.00 72914000.00 75873000.00 142361000.00 52117000.00 366013000.00 0.00
    23 Net Cash Used Provided by Financing Activities 8138000.00 309800000.00 4280000.00 12070000.00 331680000.00 24000000.00 316450000.00 75940000.00
    24 Net Change in Cash 65793000.00 34640000.00 5950000.00 -66190000.00 108320000.00 -22040000.00 39110000.00 -9230000.00
  • About
    Industry: Biotechnology
    Sector: Healthcare
    Country: nan
    IPO Date: nan
    Stonk Exchange: NASDAQ
    • nan